cirazoline has been researched along with Cancer of Pancreas in 1 studies
cirazoline: posseses agonist properties at alpha-adrenoreceptor sites; RN given refers to parent cpd
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect on insulin release of efaroxan, an alpha 2-adrenoceptor antagonist and a highly potent drug at imidazoline I1 receptors, and the effects of seven other imidazoline compounds selective for the imidazoline I1 or I2 receptors, were studied in the rat insulinoma cell line RIN-5AH." | 3.69 | Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. ( Haque, M; Kulkarni, RN; MacDermot, J; Olmos, G, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olmos, G | 1 |
| Kulkarni, RN | 1 |
| Haque, M | 1 |
| MacDermot, J | 1 |
1 other study available for cirazoline and Cancer of Pancreas
| Article | Year |
|---|---|
Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Affinity Labels; | 1994 |